Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2380-2381

  Kolibab, Kristopher ^a   Derrick, Steven C ^a   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOSYNTHESIS; BOVINE TUBERCULOSIS; DRUG ACTIVITY; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

MYCOBACTERIUM BOVIS BCG;

EID: 79957439749     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00648-11     Document Type: Letter

References (8)

1. Aljada, I. S., C. J. N. Corriere, D. G. Wagle, and D. Amsterdam. 1999. Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy. J. Clin. Microbiol. 37:2106-2108.
2. Behr, M. A., S. B. J. N. Brinkman, R. A. Slayden, and Barry CE III. 2000. A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J. Bacteriol. 182:3394-3399. (Pubitemid 30341600)
3. Koukol, S. C., D. J. D. R. Riggs, and D. L. Lamm. 1995. Drug therapy of bacillus Calmette-Guérin sepsis. Urol. Res. 22:373-376.
4. LoBue, P. 2009. Extensively drug-resistant tuberculosis. Curr. Opin. Infect. Dis. 22:167-173.
5. Matteelli, A., M. G. D. Cirillo, R. Centis, E. Girard, and M. Raviglion. 2007. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev. Anti Infect. Ther. 5:857-871.
6. Nadasy, K. A., et al. 2008. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma. South. Med. J. 101:91-95.
7. Parsons, L. M., S. A. R. Urbanczik, and M. Salfinger. 2004. Laboratory diagnostic aspects of drug resistant tuberculosis. Front. Biosci. 9:2086-2105.
8. Shelley, M. D., and M. M. H. Kynaston. 2010. Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat. Rev. 36:195-205.